Brain tumors sort into groups by their immune cells
Original title: Immune subtypes and survival in patients with primary glioma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This looked at tumor tissue from people, but no treatment was tested.
The short version
Researchers found that brain tumors differ in the immune cells inside them.
What was studied. Researchers looked at tumor tissue from 354 people with newly found glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary. The tissue was taken during their first surgery. immunohistochemistry: A way of staining a slide to show whether one protein is there in the cells. Each stain answers one question, so a report may list several of them. See the glossary showed which immune cells were in each tumor.
What they found. The grade 4 tumors fell into four immune groups. One group was rich in immune cells that help fight tumors. One group had very few immune cells, and those patients did worse. Grade 3 tumors sorted into the same four groups, and grade 2 tumors fit into some of them.
What this means, and what it doesn't
What it could mean: Tumors that look alike under a microscope may not act alike inside. In time, groups like these could help doctors tell who might be helped by immune treatments. The grouping could also help explain why some tumors grow faster than others.
What it doesn't mean: This study did not test any treatment. No one here was given a new drug. It is early lab work on tumor tissue, and it does not change care today. It does not tell any one person how they will do. It is not a promise of a cure.
Source: PubMed, October 5, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.